LY3839840

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3839840, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A First-In-Human Study of LY3839840 in Healthy Participants [Phase 1]